Lead Product(s) : Undisclosed
Therapeutic Area : Genetic Disease
Study Phase : Discovery
Sponsor : University of Wisconsin
Deal Size : Undisclosed
Deal Type : Collaboration
Details : Under the partnership, EdiGene will work with the David Gamm Laboratory to evaluate the pharmacological property of LEAPER™ RNA employs short engineered ADAR-recruiting RNAs (arRNAs) base editing candidates targeting specific genetic diseases.
Product Name : Undisclosed
Product Type : Other Large Molecule
Upfront Cash : Undisclosed
September 11, 2021
Lead Product(s) : Undisclosed
Therapeutic Area : Genetic Disease
Highest Development Status : Discovery
Sponsor : University of Wisconsin
Deal Size : Undisclosed
Deal Type : Collaboration